Paclitaxel-Associated Hypersensitivity Reactions: Experience of the Gynecologic Oncology Program of the Cleveland Clinic Cancer Center
- 1 January 2000
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 18 (1) , 102
- https://doi.org/10.1200/jco.2000.18.1.102
Abstract
PURPOSE: : This study expands the existing limited data as to whether patients developing clinically significant paclitaxel-induced hypersensitivity reactions can continue to be treated with this i...Keywords
This publication has 12 references indexed in Scilit:
- Paclitaxel in Breast CancerThe Oncologist, 1998
- The Burgeoning Role of Paclitaxel in Advanced Pulmonary MalignancyThe Oncologist, 1998
- Taxol Hypersensitivity: Rapid Retreatment Is Safe and Cost EffectiveGynecologic Oncology, 1998
- Simplified regimen for the prevention of paclitaxel-associated hypersensitivity reactions.Journal of Clinical Oncology, 1997
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Successful parenteral desensitization to paclitaxelJournal of Allergy and Clinical Immunology, 1996
- Paclitaxel (Taxol)New England Journal of Medicine, 1995
- European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion.Journal of Clinical Oncology, 1994
- Successful re-treatment with taxol after major hypersensitivity reactions.Journal of Clinical Oncology, 1993
- Hypersensitivity reactions from taxol.Journal of Clinical Oncology, 1990